Last reviewed 2026-04-20 · How we verify

PF-07275315 (pf-07275315)

At a glance

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

• A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease (PHASE2, PHASE3)
• A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma (PHASE2)
• A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis (PHASE2)
• A Study to Learn More About the Study Medicine PF-07275315 in Healthy Chinese Adult Participants (PHASE1)
• A Study to Learn How the Study Medicine Called PF-07275315 Works in Healthy People (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.